Company / Net Debt per Share
Charles River Laboratories Net Debt per Share History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$29.85
FY2018
5-year range
-
FY2016-FY2018
Trend
+53.3%
vs FY2017
Sector context
#18 of 98
Health Care
What the data says
Charles River Laboratories's net debt per share of $29.85 is higher than 82% of companies in the Health Care sector (FY2018). Increased from $22.76 to $29.85 over the past 2 years.
Based on SEC 10-K filings.
29.85 in FY2018. Top quartile in the Health Care sector.
Increased from $22.76 to $29.85 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 98This company $29.85 Sector average $7.89
▼
+278.3% above sector average
Key checks
Key Insights
- In FY2018, net debt per share increased 53.3% year-over-year.
- Ranks #18 out of 98 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $29.85 | +53.3% |
| FY2017 | $19.48 | -14.4% |
| FY2016 | $22.76 | +63.6% |
As of FY2018 · SEC 10-K · Updated Jul 4, 2026